Casimersen is an antisense oligonucleotide medication designed for the treatment of Duchenne muscular dystrophy in patients with genetic mutations amenable to exon 45 skipping. This category contains a… Read more
Casimersen is an antisense oligonucleotide medication designed for the treatment of Duchenne muscular dystrophy in patients with genetic mutations amenable to exon 45 skipping. This category contains a comprehensive selection of high-quality reference standards, impurities, metabolites, and stable isotope-labelled compounds essential for pharmaceutical research and development. These analytical tools are vital for laboratories performing rigorous impurity profiling, method validation, and routine quality control of the active pharmaceutical ingredient. By utilizing these precise reference materials, researchers can accurately identify, quantify, and monitor degradation products and process-related impurities throughout the manufacturing lifecycle. The inclusion of stable isotope-labelled standards further supports advanced mass spectrometry-based analytical methods, ensuring precise quantification and reliable results in the complex analysis of oligonucleotide therapeutics. Each product provided facilitates the maintenance of high regulatory standards and consistency in analytical testing workflows.